SCHEMBL13745378

SCHEMBL13745378

O=C1NC(=O)/C(=C/c2ccc3ncc(-c4ccccn4)n3c2)S1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 4/20 0.53
PIK3CA P42336 3/20 0.52
HPGD P15428 3/20 0.49
PIM1 P11309 1/20 0.49
PIM3 Q86V86 1/20 0.49
PIM2 Q9P1W9 1/20 0.49
MTOR P42345 5/20 0.48
GSK3B P49841 2/20 0.48
CISD1 Q9NZ45 3/20 0.47
MAOA P21397 1/20 0.47
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
HTT P42858 1/20 0.45
PIK3CD O00329 1/20 0.44
CSNK2A2 P19784 1/20 0.44
MAOB P27338 1/20 0.44
PIK3CB P42338 1/20 0.44
CLK1 P49759 1/20 0.44
CSNK2B P67870 1/20 0.44
CSNK2A1 P68400 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4256322 0.84 PIK3CG (0.47) PIK3CGPIK3CAHPGDPIM1PIM3
SCHEMBL4256326 0.84 PIK3CG (0.47) PIK3CGPIK3CAHPGDPIM1PIM3
SCHEMBL13745894 0.82 CISD1 (0.59) PIK3CGPIK3CAPIM1PIM3PIM2
SCHEMBL4258410 0.81 GSK3B (0.59) PIK3CGPIK3CAPIM1PIM3PIM2
SCHEMBL4258413 0.81 GSK3B (0.59) PIK3CGPIK3CAPIM1PIM3PIM2
SCHEMBL4250160 0.81 CISD1 (0.58) PIK3CGPIK3CAPIM1PIM3PIM2
SCHEMBL4250156 0.81 CISD1 (0.58) PIK3CGPIK3CAPIM1PIM3PIM2
SCHEMBL1250555 0.78 PIK3CA (0.63) PIK3CGPIK3CAHPGDPIM1PIM3
SCHEMBL1250553 0.78 PIK3CA (0.63) PIK3CGPIK3CAHPGDPIM1PIM3
SCHEMBL4257525 0.78 PIK3CG (0.46) PIK3CGPIK3CAHPGDPIM1PIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215818-A1 THIOZOLIDINEDIONE DERIVATIVES AS PI3 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2009-08-27 US disclosed
US-20090215818-A1 THIOZOLIDINEDIONE DERIVATIVES AS PI3 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2009-08-27 US disclosed
WO-2008014219-A2 THIOZOLIDINEDIONE DERIVATIVES AS P13 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215818-A1 THIOZOLIDINEDIONE DERIVATIVES AS PI3 KINASE INHIBITORS PIK3CD, PI4KA, PIP4K2A PIK3CG 5/4885PIK3CA 15/4885HPGD 3300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.